• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAAR1与成瘾:透过冰山一角深入探究。

TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.

作者信息

Liu Jian-Feng, Li Jun-Xu

机构信息

Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY, United States.

School of Pharmacy, Yantai University, Yantai, China.

出版信息

Front Pharmacol. 2018 Mar 27;9:279. doi: 10.3389/fphar.2018.00279. eCollection 2018.

DOI:10.3389/fphar.2018.00279
PMID:29636691
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5881156/
Abstract

Trace-amine associated receptor 1 (TAAR1) is the best-characterized member of the family of TAARs. TAAR1 is broadly expressed in the brain, especially within the monoaminergic systems. Evidence from electrophysiological and neurochemical studies evaluating the effects of genetic and pharmacological interventions on TAAR1 revealed that TAAR1 modulates transmission of monoamines, especially dopamine. TAAR1 agonists dampened drugs of abuse-induced dopamine accumulation. In general, TAAR1 agonists specifically inhibited the rewarding and reinforcing effects of drugs of abuse and drug-abuse related behaviors. Details of the mechanism of TAAR1 remain elusive; however, it is thought to be regulated by its interactions with D2 receptors. In addition, the alternative cellular mechanism such as an interaction between TAAR1 and D3 may also participate in the action of TAAR1 agonists. Further studies are required to investigate the role of TAAR1 in other drugs of abuse-related behaviors and the underlying neural mechanisms. Collectively, TAAR1 negatively modulates dopaminergic systems and dopamine-related behaviors and TAAR1 agonists are promising pharmacotherapy to treat drug addiction and relapse.

摘要

痕量胺相关受体1(TAAR1)是痕量胺相关受体(TAAR)家族中特征最为明确的成员。TAAR1在大脑中广泛表达,尤其是在单胺能系统中。评估基因和药物干预对TAAR1影响的电生理和神经化学研究证据表明,TAAR1调节单胺的传递,尤其是多巴胺。TAAR1激动剂可抑制滥用药物诱导的多巴胺积累。一般来说,TAAR1激动剂特异性地抑制滥用药物的奖赏和强化作用以及与药物滥用相关的行为。TAAR1的作用机制细节仍不清楚;然而,人们认为它是通过与D2受体的相互作用来调节的。此外,诸如TAAR1与D3之间相互作用等其他细胞机制也可能参与TAAR1激动剂的作用。需要进一步研究来探讨TAAR1在其他与药物滥用相关行为中的作用以及潜在的神经机制。总的来说,TAAR1对多巴胺能系统和与多巴胺相关的行为起负调节作用,TAAR1激动剂有望成为治疗药物成瘾和复发的药物疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4389/5881156/d20eda351ad0/fphar-09-00279-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4389/5881156/fa7b51d31376/fphar-09-00279-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4389/5881156/d20eda351ad0/fphar-09-00279-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4389/5881156/fa7b51d31376/fphar-09-00279-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4389/5881156/d20eda351ad0/fphar-09-00279-g0002.jpg

相似文献

1
TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.TAAR1与成瘾:透过冰山一角深入探究。
Front Pharmacol. 2018 Mar 27;9:279. doi: 10.3389/fphar.2018.00279. eCollection 2018.
2
Trace amine-associated receptor 1 and drug abuse.痕量胺相关受体 1 与药物滥用。
Adv Pharmacol. 2022;93:373-401. doi: 10.1016/bs.apha.2021.10.005. Epub 2021 Nov 11.
3
TAAR1 and Psychostimulant Addiction.TAAR1 与精神兴奋剂成瘾。
Cell Mol Neurobiol. 2020 Mar;40(2):229-238. doi: 10.1007/s10571-020-00792-8. Epub 2020 Jan 23.
4
Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.假设一种前多巴胺调节剂(KB220Z)应优化而非过度激活痕量胺相关受体1(TAAR-1)的活性,并长期诱导对精神兴奋剂的抗渴望作用。
J Reward Defic Syndr Addict Sci. 2016;2(1):14-21. doi: 10.17756/jrdsas.2016-023. Epub 2016 Jun 29.
5
Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.痕量胺相关受体 1 在尼古丁行为和神经化学作用中的作用。
Neuropsychopharmacology. 2018 Nov;43(12):2435-2444. doi: 10.1038/s41386-018-0017-9. Epub 2018 Feb 5.
6
Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats.痕量胺相关受体1激动剂RO5263397和RO5166017可减轻喹吡罗诱导的大鼠打哈欠,但对体温降低无影响。
Behav Pharmacol. 2017 Oct;28(7):590-593. doi: 10.1097/FBP.0000000000000330.
7
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.TAAR1介导的突触前多巴胺能神经传递调节:D2多巴胺自身受体的作用。
Neuropharmacology. 2014 Jun;81:283-91. doi: 10.1016/j.neuropharm.2014.02.007. Epub 2014 Feb 22.
8
Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D Receptor Controls Cocaine's Neurochemical Actions.痕量胺相关受体 1 与多巴胺 D 受体相互作用控制可卡因的神经化学作用。
Sci Rep. 2017 Oct 24;7(1):13901. doi: 10.1038/s41598-017-14472-z.
9
TAAR1 as an emerging target for the treatment of psychiatric disorders.TAAR1作为治疗精神疾病的一个新兴靶点。
Pharmacol Ther. 2024 Jan;253:108580. doi: 10.1016/j.pharmthera.2023.108580. Epub 2023 Dec 22.
10
Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine.痕量胺相关受体1调节尼古丁的运动和致敏作用。
Front Pharmacol. 2018 Apr 6;9:329. doi: 10.3389/fphar.2018.00329. eCollection 2018.

引用本文的文献

1
The TAAR1 Agonist PCC0105004 Regulates Amygdala Synaptic Plasticity to Alleviate Anxiety-Like Behaviors in Rats.TAAR1激动剂PCC0105004调节杏仁核突触可塑性以减轻大鼠的焦虑样行为。
Pharmacol Res Perspect. 2025 Apr;13(2):e70068. doi: 10.1002/prp2.70068.
2
Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders.痕量胺相关受体1(TAAR1):神经退行性、神经发育性和神经创伤性疾病的新兴治疗靶点。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5057-5075. doi: 10.1007/s00210-024-03757-6. Epub 2024 Dec 30.
3
Molecular Mechanisms of Methamphetamine-Induced Addiction via TAAR1 Activation.

本文引用的文献

1
Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: Effects of the TAAR 1 agonist RO5263397.在大鼠慢性 methamphetamine 治疗期间,Methamphetamine 诱导的冲动性:TAAR 1 激动剂 RO5263397 的影响。
Neuropharmacology. 2018 Feb;129:36-46. doi: 10.1016/j.neuropharm.2017.11.012. Epub 2017 Nov 8.
2
Drugs of Abuse.滥用药物
Psychiatr Clin North Am. 2017 Sep;40(3):501-517. doi: 10.1016/j.psc.2017.05.006.
3
Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats.
通过 TAAR1 激活导致甲基苯丙胺成瘾的分子机制。
J Med Chem. 2024 Oct 24;67(20):18593-18605. doi: 10.1021/acs.jmedchem.4c01961. Epub 2024 Oct 2.
4
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia.乌洛托隆:TAAR1 激动剂治疗精神分裂症的初步疗效和安全性的综述。
Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1543-1556. doi: 10.1007/s00406-023-01580-3. Epub 2023 May 10.
5
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.G 蛋白偶联受体在神经退行性疾病和精神障碍中的作用。
Signal Transduct Target Ther. 2023 May 3;8(1):177. doi: 10.1038/s41392-023-01427-2.
6
Selective TAAR1 agonists induce conditioned taste aversion.选择性 TAAR1 激动剂可诱导条件性味觉厌恶。
Psychopharmacology (Berl). 2022 Oct;239(10):3345-3353. doi: 10.1007/s00213-022-06222-5. Epub 2022 Sep 3.
7
Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.痕量胺相关受体 1(TAAR1)作为治疗阿尔茨海默病认知功能障碍的新靶点。
Int J Mol Sci. 2022 Jul 15;23(14):7811. doi: 10.3390/ijms23147811.
8
Potential therapeutic targets for the treatment of opioid abuse and pain.治疗阿片类药物滥用和疼痛的潜在治疗靶点。
Adv Pharmacol. 2022;93:335-371. doi: 10.1016/bs.apha.2021.09.002. Epub 2021 Nov 9.
9
Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.痕量胺相关受体 1(TAAR1)配体在物质使用障碍管理中的潜力。
CNS Drugs. 2021 Dec;35(12):1239-1248. doi: 10.1007/s40263-021-00871-4. Epub 2021 Nov 12.
10
The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice.选择性 TAAR1 部分激动剂 RO5263397 促进了小鼠的新颖性识别记忆。
Psychopharmacology (Berl). 2021 Nov;238(11):3221-3228. doi: 10.1007/s00213-021-05937-1. Epub 2021 Jul 22.
痕量胺相关受体1激动剂RO5263397和RO5166017可减轻喹吡罗诱导的大鼠打哈欠,但对体温降低无影响。
Behav Pharmacol. 2017 Oct;28(7):590-593. doi: 10.1097/FBP.0000000000000330.
4
Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.TAAR1在中脑皮质边缘多巴胺能系统各亚区中对可卡因觅求行为的作用。
J Neurosci. 2017 Jan 25;37(4):882-892. doi: 10.1523/JNEUROSCI.2006-16.2016.
5
Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.抗奖赏、强迫性与成瘾:阿西娜·马尔库博士对成瘾中动机失调的开创性贡献。
Psychopharmacology (Berl). 2017 May;234(9-10):1315-1332. doi: 10.1007/s00213-016-4484-6. Epub 2017 Jan 3.
6
Neuropeptide systems and new treatments for nicotine addiction.神经肽系统与尼古丁成瘾的新疗法
Psychopharmacology (Berl). 2017 May;234(9-10):1419-1437. doi: 10.1007/s00213-016-4513-5. Epub 2016 Dec 28.
7
The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats.痕量胺相关受体1激动剂RO5256390可阻断大鼠的强迫性、暴饮暴食行为。
Neuropsychopharmacology. 2017 Jun;42(7):1458-1470. doi: 10.1038/npp.2016.233. Epub 2016 Oct 6.
8
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT, D and TAAR receptors.致幻剂d-麦角酸二乙酰胺(LSD)通过5-羟色胺、多巴胺和TAAR受体降低多巴胺放电活动。
Pharmacol Res. 2016 Nov;113(Pt A):81-91. doi: 10.1016/j.phrs.2016.08.022. Epub 2016 Aug 17.
9
Expanding the definition of addiction: DSM-5 vs. ICD-11.拓展成瘾的定义:《精神疾病诊断与统计手册》第5版与《国际疾病分类》第11版之比较
CNS Spectr. 2016 Aug;21(4):300-3. doi: 10.1017/S1092852916000183. Epub 2016 May 6.
10
Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.痕量胺与痕量胺相关受体1:药理学、神经化学及临床意义
Front Neurosci. 2016 Apr 5;10:148. doi: 10.3389/fnins.2016.00148. eCollection 2016.